Cannabinoid

HYTN Partners with the UK's 4C Labs, Validates GMP Certification

Retrieved on: 
Tuesday, September 10, 2024
Cannabinoid, TGA, Health Canada, OTC, Agreement, PIC/S, Good manufacturing practice, Partnership, Psilocybin, CAD, GMP, Therapeutic Goods Administration, LABS, Drug

Through this partnership HYTN will act as the manufacturer, packager and exporter of pharmaceutical quality cannabis goods that 4C LABS may purchase and subsequently import and distribute into the UK market.

Key Points: 
  • Through this partnership HYTN will act as the manufacturer, packager and exporter of pharmaceutical quality cannabis goods that 4C LABS may purchase and subsequently import and distribute into the UK market.
  • The agreements do not provide for a fixed, mandatory or minimum order by 4C LABS.
  • “This partnership validates the ongoing regulatory work HYTN has been undertaking,” stated Elliot McKerr, Chief Executive Officer of HYTN.
  • As these markets require GMP-certified production and distribution, both firms have identified this partnership as providing the necessary framework to support global expansion.

Grön Debuts MEGAs in New Jersey

Retrieved on: 
Monday, September 9, 2024
Megas, CBN, CBG, MEGA, Cannabinoid, THC, News, Heel

PORTLAND, Ore., Sept. 09, 2024 (GLOBE NEWSWIRE) -- Grön (pronounced grewn), the Mother of All Edibles, founded by Christine Apple, the acclaimed woman-led producer of innovative, handcrafted cannabis-infused edibles, today announces the launch of their MEGAs across the state of New Jersey. This news comes on the heels of several MEGA launches across the U.S., including Ohio and Missouri.

Key Points: 
  • PORTLAND, Ore., Sept. 09, 2024 (GLOBE NEWSWIRE) -- Grön (pronounced grewn), the Mother of All Edibles, founded by Christine Apple, the acclaimed woman-led producer of innovative, handcrafted cannabis-infused edibles, today announces the launch of their MEGAs across the state of New Jersey.
  • This news comes on the heels of several MEGA launches across the U.S., including Ohio and Missouri.
  • “We launched in New Jersey in January of this year, and over the past eight months, we have been met with such open arms,” said Christine Apple, Founder and CEO of Grön.
  • “Our Sugar-Coated Pearls have become a fan favorite in the state, so bringing MEGAs with higher dosing options for our New Jersey consumers was a must.”

Tilray Medical Supports Scientific Study on Fibromyalgia With Positive Outcomes: Effectiveness of Cannabinoids Treatment in Pain Management and Other Fibromyalgia-Associated Symptoms

Retrieved on: 
Monday, September 9, 2024
Epilepsy, International, Science, Fibromyalgia, Vomiting, CBD, TLRY, Essential tremor, Cannabinoid, THC, Post-traumatic stress disorder, Patient, Health, Pain, Pain management, Sleep, HIV, Quality of life, Tilray, TSX, Chronic pain, Treatment, Nursing

The study examines the real-world impact of cannabinoid treatments on patients with fibromyalgia (FM) under the guidance of healthcare providers.

Key Points: 
  • The study examines the real-world impact of cannabinoid treatments on patients with fibromyalgia (FM) under the guidance of healthcare providers.
  • The TOMAS study, consisting of patients with an average age of 52 years, examined the effects of Tilray Dried Flower THC18 on chronic pain and other FM-associated symptoms.
  • The study sheds light on the impact of cannabinoids on health outcomes, with a particular focus on pain, sleep, and quality of life.
  • With medical cannabis guidance and supervision, the study demonstrated improvements in pain scores, sleep quality, and overall quality of life for fibromyalgia patients.

Grön Introduces 10-Pack MEGAs to Arizona’s Medical Cannabis Market, Available Exclusively at Trulieve

Retrieved on: 
Wednesday, September 4, 2024
MEGA, THC, CBN, Pog (drink), Prunus, Partnership, Megas, Pearl, Cannabinoid, Patient, Tea

PORTLAND, Ore., Sept. 04, 2024 (GLOBE NEWSWIRE) -- Grön (pronounced grewn), the Mother of All Edibles, founded by Christine Apple, the acclaimed woman-led producer of innovative, handcrafted cannabis-infused edibles, today announces the expansion of its product size offerings across multiple states. The launch includes the introduction of a new 10-pack option of their beloved MEGAs, now available for medical cannabis patients in Arizona, via an exclusive partnership with Trulieve. As part of Grön’s expansion strategy following a successful first two quarters in 2024, the company also announces a new 2-Pack option of their beloved Sugar-Coated Pearls, now available in Arizona, Missouri, New York, and New Jersey.

Key Points: 
  • The launch includes the introduction of a new 10-pack option of their beloved MEGAs, now available for medical cannabis patients in Arizona, via an exclusive partnership with Trulieve .
  • Medical cannabis patients in Arizona will be able to purchase the 10-Pack MEGAs in three delicious flavors: Cherry Limeade (indica), Passion Orange Guava (POG) (hybrid), and Lemonade (sativa).
  • Additionally, Grön today announced the launch of their 2-Pack Sugar-Coated Pearls, which will now be available in adult-use markets in Arizona, Missouri, New Jersey, and New York.
  • The 2-Pack provides a cost-effective and accessible way to introduce consumers to the Grön brand and its diverse edible flavors.

Rare Cannabinoid Company Unveils Incredible Price Drops on THCV, CBDV, CBN & More + A Special Offer On THC + CBC Mood Mints For Labor Day Weekend

Retrieved on: 
Saturday, August 31, 2024
BOGO, Sleep, Oil, CBG, THC, CBN, THCV, CBC, Coconut oil, CBD, Appetite, CBDV, Labour, Cannabinoid, Irritability, MCT, Edible

HONOLULU, Aug. 31, 2024 /PRNewswire-PRWeb/ -- Rare Cannabinoid Company is celebrating Labor Day Weekend with incredible deals on its most popular cannabinoid products. Whether you're seeking enhanced mood, energy, focus, improved sleep, or relief from discomfort, these exclusive offers make it easier than ever to discover the benefits of rare cannabinoids.

Key Points: 
  • In addition, their featured deal is: Buy one get one half off new, fast-acting nano THC + CBC Mood Mints.
  • HONOLULU, Aug. 31, 2024 /PRNewswire-PRWeb/ -- Rare Cannabinoid Company is celebrating Labor Day Weekend with incredible deals on its most popular cannabinoid products.
  • One of the highlights of their Labor Day offers is the Buy One, Get One 50% off deal on the newly launched THC + CBC Mood Mints .
  • Established in 2017 and based in Hawaii, Rare Cannabinoid Company is a pioneer in the development of premium cannabinoid products.

Curaleaf Launches Innovative JAMS Remix Fast-Acting Ratio Jellies

Retrieved on: 
Friday, August 30, 2024
Patient, CBG, JAMS, Cannabinoid, B12, Growth, TSX, Food preservation

STAMFORD, Conn., Aug. 30, 2024 /PRNewswire/ -- Curaleaf Holdings, Inc. (TSX: CURA) (OTCQX: CURLF) ("Curaleaf" or the "Company"), a leading international provider of consumer cannabis products, today announced the launch of JAMS Remix, a new line of flavor-forward jellies. JAMS Remix pairs fast-acting onset technology with unique multi-cannabinoid ratios and functional ingredients to deliver cannabis benefits from daytime to nighttime, with Shineapple for morning, Sootheberry for mid-day and Lullaberry for night.

Key Points: 
  • STAMFORD, Conn., Aug. 30, 2024 /PRNewswire/ -- Curaleaf Holdings, Inc. (TSX: CURA) (OTCQX: CURLF) ("Curaleaf" or the "Company"), a leading international provider of consumer cannabis products, today announced the launch of JAMS Remix, a new line of flavor-forward jellies.
  • JAMS Remix pairs fast-acting onset technology with unique multi-cannabinoid ratios and functional ingredients to deliver cannabis benefits from daytime to nighttime, with Shineapple for morning, Sootheberry for mid-day and Lullaberry for night.
  • In the expanding cannabis edibles category, JAMS Remix is uniquely positioned to deliver the products consumers seek to achieve their desired mood, with innovation at its core.
  • JAMS Remix is the latest addition to the cannabis-infused edibles brand JAMS .

FlackTek™ Technology Reduces Cannabinoid Degradation During Solvent Removal

Retrieved on: 
Wednesday, August 28, 2024
Research, Cannabinoid, Food, Risk, Medicinal plants

LANDRUM, S.C., Aug. 28, 2024 /PRNewswire/ -- A pivotal study, "Approaches to Mitigate Cannabinoid Degradation During Solvent Removal," showcases how FlackTek™ technology effectively protects cannabinoids during the solvent removal process in cannabis extracts.

Key Points: 
  • LANDRUM, S.C., Aug. 28, 2024 /PRNewswire/ -- A pivotal study, "Approaches to Mitigate Cannabinoid Degradation During Solvent Removal," showcases how FlackTek™ technology effectively protects cannabinoids during the solvent removal process in cannabis extracts.
  • FlackTek™'s innovative approach substantially shortens the solvent removal time and minimizes the exposure of cannabinoids to harmful conditions that can lead to degradation.
  • "This technology is changing the landscape of cannabis product manufacturing by ensuring that the beneficial properties of cannabinoids are not compromised during production."
  • "This research underscores the effectiveness of FlackTek™ technology in protecting cannabinoids during the solvent-removal process," stated Ted Reynolds, cannabis director at FlackTek. "

SciSparc Grants Global Rights for Pain Therapy to Biotech Company in Agreement Worth up to $6 Million

Retrieved on: 
Wednesday, August 28, 2024
Central nervous system, TEL, Chronic pain, Asset, Pain, License, Cannabinoid, Disorder, Morphine, Peripheral nervous system, Pharmaceutical industry

TEL AVIV, Israel, Aug. 28, 2024 (GLOBE NEWSWIRE) -- SciSparc Ltd. (Nasdaq: SPRC) ("Company" or "SciSparc"), a specialty clinical-stage pharmaceutical company focusing on the development of therapies to treat disorders and rare diseases of the central nervous system, announced that it has finalized an Exclusive Patent License Agreement (“the License Agreement”) with Polyrizon Ltd. (“Polyrizon”), for the out-licensing of its SCI-160 program (the “Assets”) for the treatment of pain.

Key Points: 
  • As announced on August 15, 2024, Polyrizon will receive exclusive, royalty-bearing global license to develop and sublicense the Assets.
  • In exchange, SciSparc would be entitled to receive consideration valued at $3 million in Polyrizon securities, as well as potentially milestone fees of approximately $3 million in cash, if certain development milestones will be met, as well as royalties.
  • SCI-160 is an innovative, proprietary synthetic combination of cannabinoids and N- acylethanolamines in the field of pain treatment.
  • Mr. Oz Adler, SciSparc’s Chief Executive Officer and Chief Financial Officer, is a member of the board of directors of Polyrizon.

Grön Launches Two New MEGA 10-Packs in Missouri

Retrieved on: 
Wednesday, August 28, 2024
THC, Pain, MEGA, CBN, Cannabinoid, CBG, Edible, Blackberry, Good, Inflammation, Amusement park

PORTLAND, Ore., Aug. 28, 2024 (GLOBE NEWSWIRE) -- Grön (pronounced grewn), the Mother of All Edibles, founded by Christine Apple, the acclaimed woman-led producer of innovative, handcrafted cannabis-infused edibles, today announced the launch of two new flavors of their MEGA 1000mg THC 10-Packs with distinct cannabinoid ratios across the state of Missouri (MO). This will be the first high-dose product with effect-based ratios offered on the market in MO.

Key Points: 
  • The MEGA 10-Packs, the heavyweight champion of edibles weighs in at nearly a half pound per pack.
  • Bursting with fruit flavors and infused with cannabis extract, the MEGA 10-Packs contain 10 larger-than-life MEGAs totaling 1,000 milligrams of THC per package.
  • “We’re excited to expand our flavor profiles within our MEGA 10-packs product line, providing customers with more options and range.
  • Earlier this year we launched the MEGA 10-Packs in Missouri with three of our popular flavors and have since received glowing reviews,” said Christine Apple, Founder and CEO of Grön.

CV Sciences Launches +PlusHLTH, a New Line of Cannabinoid-Free Supplements

Retrieved on: 
Tuesday, August 27, 2024
OTCQB, CBD, Collection, Health, Lion's mane, Pet, Huperzine A, Wort, Metabolism, Cannabinoid, Memory, Relaxation, Berberine, Ocimum tenuiflorum, DMAE, Dietary supplement

SAN DIEGO, Aug. 27, 2024 /PRNewswire/ -- CV Sciences, Inc. (OTCQB: CVSI) (the "Company", "CV Sciences", "our", "us" or "we"), a preeminent consumer wellness company specializing in hemp extracts and other proven, science-backed natural ingredients and products, today announced the launch of +PlusHLTH™, an all-new line of cannabinoid-free supplements delivering targeted formulations for optimized health, improved performance, and increased vitality. Rooted in rigorous science and fortified by clinically proven wellness ingredients, the new line is now available nationwide at select retailers and from the Company's website at https://www.pluscbdoil.com/plushlth.html.

Key Points: 
  • +PlusHLTH™ offers supplements that naturally enhance focus, mood, energy levels, metabolism, and more.
  • "+PlusHLTH™ fills a growing demand for natural supplements that address today's key wellness challenges, offering consumers a cannabinoid-free alternative or complement to our best-selling CBD-based product line, +PlusCBD™," said Joseph Dowling, CEO of CV Sciences.
  • +PlusHLTH™ is not your average line of wellness supplements; it's a pathway to becoming your best self."
  • +PlusHLTH™ adds to CV Sciences' expansive collection of health and wellness products curated to help individuals excel in their daily endeavors.